Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.9680
-0.0066 (-0.68%)
At close: Jul 2, 2025, 4:00 PM
0.9700
+0.0020 (0.21%)
After-hours: Jul 2, 2025, 7:30 PM EDT
Iterum Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
9
Market Cap
38.72M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
ITRM News
- 9 hours ago - Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 days ago - Iterum Names Christine Coyne as Chief Commercial Officer to Lead ORLYNVAH™ Launch and Commercial Growth - GlobeNewsWire
- 7 days ago - Iterum Therapeutics Announces Publication of REASSURE Trial in NEJM Evidence - GlobeNewsWire
- 21 days ago - Iterum Therapeutics Announces Partnership for Commercialization Services - GlobeNewsWire
- 6 weeks ago - Iterum Therapeutics Announces Extension of Term of Promissory Note - GlobeNewsWire
- 7 weeks ago - Iterum Therapeutics plc (ITRM) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Iterum Therapeutics Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Iterum Therapeutics to Report First Quarter 2025 Financial Results on May 13, 2025 - GlobeNewsWire